{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:14:14Z","timestamp":1791112454171,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.ando.2007.02.002","type":"journal-article","created":{"date-parts":[[2008,1,26]],"date-time":"2008-01-26T20:31:41Z","timestamp":1201379501000},"page":"138-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Apr\u00e8s le\u00a0r\u00e9cepteur des\u00a0LDL et\u00a0l'apolipoprot\u00e9ine B, l'hypercholest\u00e9rol\u00e9mie familiale r\u00e9v\u00e8le son\u00a0troisi\u00e8me protagoniste : PCSK9"],"prefix":"10.1016","volume":"68","author":[{"given":"M.","family":"Abifadel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-P.","family":"Rab\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Boileau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Varret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ando.2007.02.002_bib1","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ng1161","article-title":"Mutations in PCSK9 cause autosomal dominant hypercholesterolemia","volume":"34","author":"Abifadel","year":"2003","journal-title":"Nat. Genet."},{"issue":"11","key":"10.1016\/j.ando.2007.02.002_bib2","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1051\/medsci\/20062211916","article-title":"PCSK9, du g\u00e8ne \u00e0 la prot\u00e9ine: un nouvel acteur dans l\u2019hom\u00e9ostasie du cholest\u00e9rol","volume":"22","author":"Abifadel","year":"2006","journal-title":"Med. Sci. (Paris)"},{"issue":"5","key":"10.1016\/j.ando.2007.02.002_bib3","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/humu.9383","article-title":"Novel Mutations of the PCSK9 Gene Cause Variable Phenotype of Autosomal Dominant Hypercholesterolemia","volume":"26","author":"Allard","year":"2005","journal-title":"Hum. Mutat."},{"issue":"47","key":"10.1016\/j.ando.2007.02.002_bib4","doi-asserted-by":"crossref","first-page":"48865","DOI":"10.1074\/jbc.M409699200","article-title":"NARC-1\/PCSK9 and its natural mutants: zymogen cleavage and effects on the low-density lipoprotein (LDL) receptor and LDL cholesterol","volume":"279","author":"Benjannet","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ando.2007.02.002_bib5","doi-asserted-by":"crossref","first-page":"30561","DOI":"10.1074\/jbc.M606495200","article-title":"The proprotein convertase PCSK9 is inactivated by furin and\/or PC5\/6A: Functional consequences of natural mutations and post-translational modifications","volume":"281","author":"Benjannet","year":"2006","journal-title":"J Biol Chem."},{"issue":"5","key":"10.1016\/j.ando.2007.02.002_bib6","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/01.ATV.0000204337.81286.1c","article-title":"Missense mutations in the PCSK9 gene are associated with hypocholesterolemia and possibly increased response to statin therapy","volume":"26","author":"Berge","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ando.2007.02.002_bib7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1126\/science.3513311","article-title":"\"A receptor mediated pathway for cholesterol homeostasis\"","volume":"232","author":"Brown","year":"1986","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.ando.2007.02.002_bib8","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/hmg\/ddl077","article-title":"Effect of mutations in the PCSK9 gene on the cell surface LDL receptors","volume":"15","author":"Cameron","year":"2006","journal-title":"Hum. Mol. Genet."},{"issue":"45","key":"10.1016\/j.ando.2007.02.002_bib9","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.jacc.2005.01.051","article-title":"A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and severity of coronary atherosclerosis","volume":"17","author":"Chen","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.ando.2007.02.002_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ng1509","article-title":"Low LDL cholesterol in individuals of African descent resulting from frequent non-sense mutations in PCSK9","volume":"37","author":"Cohen","year":"2005","journal-title":"Nat. Genet."},{"issue":"12","key":"10.1016\/j.ando.2007.02.002_bib11","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","author":"Cohen","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.ando.2007.02.002_bib12","doi-asserted-by":"crossref","first-page":"6211","DOI":"10.1074\/jbc.M508582200","article-title":"Hepatic PCSK9 expression is regulated by nutritional status via insulin and sterol regulatory element-binding protein 1c","volume":"281","author":"Costet","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.ando.2007.02.002_bib13","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1161\/01.ATV.0000134621.14315.43","article-title":"Statins upregulate PCSK9, the gene encoding the proprotein convertase neural apoptosis-regulated convertase-1 implicated in familial hypercholesterolemia","volume":"24","author":"Dubuc","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.ando.2007.02.002_bib14","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1471-2350-7-66","article-title":"The E670G SNP in the PCSK9 gene is associated with polygenic hypercholesterolemia in men but not in women","volume":"7","author":"Evans","year":"2006","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.ando.2007.02.002_bib15","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1126\/science.1060458","article-title":"\"Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein\"","volume":"292","author":"Garcia","year":"2001","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ando.2007.02.002_bib16","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1139\/o05-155","article-title":"Expression and localization of PCSK9 in rat hepatic cells","volume":"84","author":"Grozdanov","year":"2006","journal-title":"Biochem. Cell Biol."},{"issue":"6","key":"10.1016\/j.ando.2007.02.002_bib17","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0022-2275(20)33515-X","article-title":"Evidence for a third genetic locus causing familial hypercholesterolemia. A non-LDLR, non-APOB kindred","volume":"40","author":"Haddad","year":"1999","journal-title":"J. Lipid Res."},{"issue":"21","key":"10.1016\/j.ando.2007.02.002_bib18","doi-asserted-by":"crossref","first-page":"12027","DOI":"10.1073\/pnas.1534923100","article-title":"Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes","volume":"100","author":"Horton","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.ando.2007.02.002_bib19","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1161\/01.ATV.20.4.1089","article-title":"Genetic localization to chromosome 1p32 of the third locus for familial hypercholesterolemia in Utah kindred","volume":"20","author":"Hunt","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"19","key":"10.1016\/j.ando.2007.02.002_bib20","doi-asserted-by":"crossref","first-page":"6919","DOI":"10.1073\/pnas.84.19.6919","article-title":"Familial defective apolipoprotein B-100: low-density lipoproteins with abnormal receptor binding","volume":"84","author":"Innerarity","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.ando.2007.02.002_bib21","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0022-2275(20)39771-6","article-title":"Low-density lipoprotein receptors in rat adipose cells: subcellular localization and regulation by insulin","volume":"35","author":"Kraemer","year":"1994","journal-title":"J. Lipid Res."},{"issue":"3","key":"10.1016\/j.ando.2007.02.002_bib22","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1086\/500615","article-title":"A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol","volume":"78","author":"Kotowski","year":"2006","journal-title":"Am. J. Hum. Genet."},{"issue":"5","key":"10.1016\/j.ando.2007.02.002_bib23","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.0009-9163.2004.0238.x","article-title":"Mutations in the PCSK9 gene in Norwegian subjects with autosomal dominant hypercholesterolemia","volume":"65","author":"Leren","year":"2004","journal-title":"Clin. Genet."},{"issue":"11","key":"10.1016\/j.ando.2007.02.002_bib24","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1194\/jlr.M300203-JLR200","article-title":"Novel putative SREBP and LXR target genes identified by microarray analysis in liver of cholesterol-fed mice","volume":"44","author":"Maxwell","year":"2003","journal-title":"J. Lipid Res."},{"issue":"18","key":"10.1016\/j.ando.2007.02.002_bib25","doi-asserted-by":"crossref","first-page":"7100","DOI":"10.1073\/pnas.0402133101","article-title":"Adenoviral-mediated expression of PCSK9 in mice results in a low-density lipoprotein receptor knockout phenotype","volume":"101","author":"Maxwell","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.ando.2007.02.002_bib26","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1073\/pnas.0409736102","article-title":"Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment","volume":"102","author":"Maxwell","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.ando.2007.02.002_bib27","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1161\/01.ATV.0000190668.94752.ab","article-title":"Severe hypercholesterolemia in four British families with the D374Y mutation in the PCSK9 gene: long-term follow-up and treatment response","volume":"25","author":"Naoumova","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"8","key":"10.1016\/j.ando.2007.02.002_bib28","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1161\/01.ATV.0000133684.77013.88","article-title":"Apolipoprotein B100 metabolism in autosomal-dominant hypercholesterolemia related to mutations in PCSK9","volume":"24","author":"Ouguerram","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.ando.2007.02.002_bib29","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.atherosclerosis.2005.08.015","article-title":"Additive effect of mutations in LDLR and PCSK9 genes on the phenotype of familial hypercholesterolemia","volume":"186","author":"Pisciotta","year":"2006","journal-title":"Arteriosclerosis"},{"issue":"3","key":"10.1016\/j.ando.2007.02.002_bib30","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1471-4159.2006.03928.x","article-title":"Implication of the proprotein convertase NARC-1\/PCSK9 in the development of the nervous system","volume":"98","author":"Poirier","year":"2006","journal-title":"J. Neurochem."},{"issue":"15","key":"10.1016\/j.ando.2007.02.002_bib31","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.1073\/pnas.0501652102","article-title":"Decreased plasma cholesterol and hypersensitivity to statins in mice lacking PCSK9","volume":"102","author":"Rashid","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ando.2007.02.002_bib32","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/sj.ejhg.5200516","article-title":"\"Autosomal dominant type IIa hypercholesterolemia: evaluation of the respective contributions of LDLR and APOB genes defects as well as a third major group of defects\"","volume":"8","author":"Saint-Jore","year":"2000","journal-title":"Eur. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.ando.2007.02.002_bib33","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1073\/pnas.0335507100","article-title":"The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation","volume":"100","author":"Seidah","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.ando.2007.02.002_bib34","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10038-003-0114-3","article-title":"Genetic variants in PCSK9 affect the cholesterol level in Japanese","volume":"49","author":"Shioji","year":"2004","journal-title":"J. Hum. Genet."},{"issue":"9","key":"10.1016\/j.ando.2007.02.002_bib35","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/hmg\/ddi128","article-title":"Evidence for effect of mutant PCSK9 on apolipoprotein B secretion as the cause of unusually severe dominant hypercholesterolaemia","volume":"14","author":"Sun","year":"2005","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/j.ando.2007.02.002_bib36","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00439-003-1071-9","article-title":"A mutation in PCSK9 causing autosomal-dominant hypercholesterolemia in a Utah pedigree","volume":"114","author":"Timms","year":"2004","journal-title":"Hum. Genet."},{"issue":"5","key":"10.1016\/j.ando.2007.02.002_bib37","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1086\/302370","article-title":"A third major locus for autosomal dominant hypercholesterolemia maps to 1p34.1-p32","volume":"64","author":"Varret","year":"1999","journal-title":"Am. J. Hum. Genet."},{"issue":"A216","key":"10.1016\/j.ando.2007.02.002_bib38","article-title":"Detection and mapping of HCHOLA4, the fourth gene involved in familial hypercholesterolemia","volume":"207","author":"Villeger","year":"2002","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.ando.2007.02.002_bib39","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/humu.10102","article-title":"The UMD-LDLR database: additions to the software and 490 new entries to the database","volume":"20","author":"Villeger","year":"2002","journal-title":"Hum. Mutat."},{"issue":"5","key":"10.1016\/j.ando.2007.02.002_bib40","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/humu.20316","article-title":"The c.43_44insCTG variation in PCSK9 is associated with low plasma LDL-cholesterol in a Caucasian population","volume":"27","author":"Yue","year":"2006","journal-title":"Hum. Mutat."},{"issue":"3","key":"10.1016\/j.ando.2007.02.002_bib41","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1086\/507488","article-title":"Molecular Characterization of Loss-of-Function Mutations in PCSK9 and identification of a Compound Heterozygote","volume":"79","author":"Zhao","year":"2006","journal-title":"Am. J. Hum. Genet."}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426607000376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426607000376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:42:07Z","timestamp":1757716927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426607000376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":41,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0003426607000376"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2007.02.002","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apr\u00e8s le\u00a0r\u00e9cepteur des\u00a0LDL et\u00a0l'apolipoprot\u00e9ine B, l'hypercholest\u00e9rol\u00e9mie familiale r\u00e9v\u00e8le son\u00a0troisi\u00e8me protagoniste: PCSK9","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2007.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}